Publication Name	World Journal of Obstetrics and Gynecology
Manuscript ID	21186
Country	United States

Received	2015-06-30 09:35
Peer-Review Started	2015-07-05 12:30
To Make the First Decision	2015-10-08 16:07
Return for Revision	2015-10-13 14:04
Revised	2015-11-07 06:34
Second Decision	2015-12-18 11:27
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2016-01-04 16:20
Articles in Press	2016-01-04 16:20
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2016-01-23 20:23
Publish the Manuscript Online	2016-01-31 19:20

ISSN	2218-6220 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Obstetrics & Gynecology
Manuscript Type	Review
Article Title	Human papilloma virus vaccination: Review article and an update
Manuscript Source	Invited Manuscript
All Author List	Zahra Maleki
Funding Agency and Grant Number
Corresponding Author	Zahra Maleki, MD, Assistant Professor of Pathology, Department of Pathology, Division of Cytology, the Johns Hopkins Hospital, 600 N. Wolfe Street/Pathology 412C, Baltimore, MD 21287, United States. zmaleki1@jhmi.edu
Key Words	Human papilloma virus; Cervarix; Gardasil; Gardasil 9; Vaccine; Review
Core Tip	Human papilloma virus (HPV) is sexually transmitted in both genders and it is a global issue. High risk HPVs are associated with a variety of cancers and low risk HPVs are associated with genital warts. HPV types 16 and 18 account for 70% of cervical cancer in women. Bivalent (Cervarix), and quadrivalent (Gardasil) vaccines are recommended to prevent HPV 16 and 18 related cancers with additional protective effect of Gardasil against HPV 6 and 11. Herein, HPV-related cancers and their incidences, low risk HPV related neoplasms and HPV vaccines, their efficacy and safety are reviewed. Moreover, the obstacles for global vaccination are addressed.
Publish Date	2016-01-31 19:20
Citation	Maleki Z. Human papilloma virus vaccination: Review article and an update. World J Obstet Gynecol 2016; 5(1): 16-27
URL	http://www.wjgnet.com/2218-6220/full/v5/i1/16.htm
DOI	http://dx.doi.org/10.5317/wjog.v5.i1.16

Full Article (PDF)	WJOG-5-16.pdf
Full Article (Word)	WJOG-5-16.doc
Manuscript File	21186-Review.docx
Answering Reviewers	21186-Answering reviewers.pdf
Audio Core Tip	21186-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	21186-Conflict-of-interest statement.pdf
Copyright License Agreement	21186-Copyright assignment.pdf
Peer-review Report	21186-Peer-review(s).pdf
Scientific Misconduct Check	21186-Scientific misconduct check.pdf
Scientific Editor Work List	21186-Scientific editor work list.pdf